Medication info

Cosalex Tablet 10/50 Milligrams

Prescription medicationOralApproval withdrawn
Ingredient · strength
Amlodipine Besylate›13.888mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
Pink rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201904761 · Approved 2019.07.16

This product's status changed to Approval withdrawn on 2024.03.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Initial treatment of essential hypertension and stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the dose be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows: - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to treat should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment goal with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min). However, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients treated with high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older patients: In patients 75 years of age or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
Use of this medicine is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Initial treatment of essential hypertension and stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used in patients with essential hypertension who do not achieve adequate blood pressure control with monotherapy of amlodipine or losartan. Additionally, it is used as initial therapy in patients with stage 2 hypertension who require combination therapy to reach the target blood pressure. It helps in effectively controlling hypertension and stabilizing blood pressure.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the dose be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows: - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to treat should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment goal with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min). However, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients treated with high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older patients: In patients 75 years of age or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

Use of this medicine is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Precautions

This drug can cause serious harm to the fetus if taken during pregnancy, especially during the second and third trimesters, and must be discontinued immediately upon confirmation of pregnancy. Pregnant women taking this drug may experience serious problems such as decreased fetal kidney function, hypotension, and cranial formation anomalies. Patients with reduced effective blood volume, for example, those on diuretics, may experience hypotension upon initial administration of this drug, so caution is required. This drug should not be administered to patients who are allergic to the active ingredients or similar components, pregnant or potentially pregnant women, patients with severe liver dysfunction, significant aortic stenosis, or those in a state of shock. Patients with reduced effective blood volume or those on stringent salt restrictions, moderate to severe renal dysfunction, or hyperkalemia should be administered this drug cautiously. This medication can cause various side effects such as dizziness, headache, drowsiness, edema, dyspepsia, and skin rash, and if any unusual symptoms occur, medical consultation should be sought immediately. Due to its blood pressure-lowering effects, dizziness or orthostatic hypotension may occur, so caution should be taken with high-risk activities such as working at heights or driving. Patients with impaired liver or kidney function may require dose adjustments, and due to the risk of hyperkalemia, potassium levels should be monitored regularly when used in combination with potassium supplements or potassium-sparing diuretics. This medication may have an enhanced effect when used together with other antihypertensive agents, so it should be taken cautiously under medical supervision. It is advisable for pregnant or breastfeeding women not to take this drug, and its safety for children has not been established, so it is not recommended. In case of overdose, severe hypotension or cardiac issues may occur, so prescribed doses should be adhered to, and immediate medical attention should be sought in case of unusual symptoms. This medication should be kept out of the reach of children, and transferring it to other containers may lead to quality deterioration or accidents, so caution is required.

Side effects

  • Hypotension
  • neonatal skull formation deficiency
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb contraction
  • craniofacial malformation
  • pulmonary hypoplasia
  • prematurity
  • intrauterine growth retardation
Show 160 more
  • patent ductus arteriosus
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early fullness
  • peripheral edema
  • dependent edema
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • polyuria
  • fatigue
  • edema
  • vasculitis
  • hypertonia
  • sensory loss
  • paresthesia
  • peripheral neuropathy
  • syncope
  • dysgeusia
  • tremor
  • erectile dysfunction
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased frequency of urination
  • urination disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • constipation
  • cutaneous hyperemia
  • spotty papular rash
  • dizziness
  • heat sensation
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • edema
  • appetite loss
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • decreased sensitivity
  • reduced libido
  • memory impairment
  • migraine
  • neural hypersensitivity
  • panic disorder
  • sleep disorder
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • dermatitis
  • dry skin
  • purpura
  • erythema
  • photosensitivity
  • sweating
  • erythroderma
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • visual impairment
  • urethral infection
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • fatigue
  • rhabdomyolysis
  • dysgeusia
  • dry cough
  • liver dysfunction
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • increased serum creatinine
  • hypotension
  • shock symptoms
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylaxis syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius. Proper storage can help maintain the effectiveness of the medication for a longer time.

Appearance and packaging

Appearance

Pink rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.